Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BMS1 pseudogene 9 (BMS1P9) is classified as a pseudogene—specifically, a nonfunctional DNA sequence that closely resembles the protein-coding gene BMS1 ribosome biogenesis factor[5][3]. It does not encode a functional protein and is not considered an enzyme, receptor, or other actionable drug target. Pseudogenes like BMS1P9 may arise from gene duplication or retrotransposition events and typically do not have direct biological functions, although some pseudogenes in general can serve regulatory roles through RNA-based mechanisms[3][9]. There is no evidence that BMS1P9 is involved in disease, serves as a biomarker, or interacts with any drugs. It is part of a family of pseudogenes related to the functional BMS1 gene, with counterparts found on multiple human chromosomes[5][1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BMS1 pseudogene 9 (BMS1P9).